Chemical Specifications
At the American Diabetes Association's Scientific Sessions, Mass General Brigham researcher Vanita Aroda, MD, presented results from SOLSTICE, a phase 2b randomized, placebo-controlled clinical trial evaluating the oral GLP-1 receptor agonist elecoglipron
Like air, food, and water, you cant live without sleep but you can limp through life on inadequate sleep
10.1111/1440-1681.13696 23 MarcusR.JosefL.BottM
Introduction Almost 2040% of the adult population all over the world and approximately 5075% of patients with type 2 diabetes (T2D) are diagnosed with non-alcoholic fatty liver (NAFL: histologically documented 5% fat or more in the liver) disease (NAFLD), after the exclusion of excess alcohol intake (recent or ongoing) and other causes of secondary or monogenic liver steatosis [1]
Always prioritize your health and well-being by staying informed and seeking professional guidance